Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity

L Wu, X Li, X Qian, S Wang, J Liu, J Yan - Vaccines, 2024 - mdpi.com
In recent years, lipid nanoparticles (LNPs) have attracted extensive attention in tumor
immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great …

Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases

J Su, J Desmarais, CQ Chu, J Zhu - Best Practice & Research Clinical …, 2024 - Elsevier
Fibrosis is commonly associated with chronic rheumatic diseases, and causes substantial
morbidity and mortality. Treatment of fibrosis is extremely challenging but is badly needed …

[HTML][HTML] Fibroblast activation protein (FAP)-mediated cleavage of type III collagen reveals serum biomarker potential in non-small cell lung cancer and …

RS Pedersen, J Thorlacius-Ussing, MG Raimondo… - Biomedicines, 2024 - mdpi.com
Fibroblast activation protein (FAP) is a known promoter of tumor development and is
associated with poor clinical outcome for various cancer types. Being specifically expressed …

[HTML][HTML] Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis

H Qian, C Deng, S Chen, X Zhang, Y He, J Lan… - Arthritis Research & …, 2024 - Springer
Fibroblast-like synoviocytes (FLSs) play a central role in RA pathogenesis and are the main
cellular component in the inflamed synovium of patients with rheumatoid arthritis (RA). FLSs …

Lipid Nanoparticle (LNP) Delivery Vector-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity

L Wu, X Li, X Qian, S Wang, J Liu, J Yan - 2023 - preprints.org
Lipid nanoparticles (LNPs) have attracted extensive attention in tumor immunotherapy in
recent years. The strategy of targeting immune cells in cancer therapy has become a …